Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada – Clinical Trials Group (NCIC-CTG)

Maureen Trudeau, Michael Crump, Danielle Charpentier, Louise Yelle, Louise Bordeleau, S. Matthews, Elizabeth A. Eisenhauer

Annals of Oncology · 2006 · 114 citations · 15 references

DOIFull text

Open access

Concepts

References

15